Business Description
Actavia Life Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US7538881068
Description
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -44.53 | |||||
| Debt-to-Equity | -0.14 | |||||
| Debt-to-EBITDA | -0.88 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 55 | |||||
| 3-Year EPS without NRI Growth Rate | 3.1 | |||||
| 3-Year Book Growth Rate | 57.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 48.26 | |||||
| 14-Day RSI | 48.19 | |||||
| 6-1 Month Momentum % | -76.33 | |||||
| 12-1 Month Momentum % | -48.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -123.7 | |||||
| Shareholder Yield % | -1.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -9.85 | |||||
| EV-to-EBITDA | -9.85 | |||||
| EV-to-FCF | -51.36 | |||||
| Earnings Yield (Greenblatt) % | -10.15 | |||||
| FCF Yield % | -2.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RASP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Actavia Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | -114.32 | ||
| Volatility % | 217.88 | ||
| 14-Day RSI | 48.19 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.004 | ||
| 12-1 Month Momentum % | -48.05 | ||
| 52-Week Range ($) | 0.0016 - 0.039 | ||
| Shares Outstanding (Mil) | 771.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Actavia Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Actavia Life Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Actavia Life Sciences Inc Frequently Asked Questions
What is Actavia Life Sciences Inc(RASP)'s stock price today?
The current price of RASP is $0.00. The 52 week high of RASP is $0.04 and 52 week low is $0.00.
When is next earnings date of Actavia Life Sciences Inc(RASP)?
The next earnings date of Actavia Life Sciences Inc(RASP) is .
Does Actavia Life Sciences Inc(RASP) pay dividends? If so, how much?
Actavia Life Sciences Inc(RASP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers